StockData
CYHNYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31

COMMUNITY HEALTH SYSTEMS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 23, 2026
$2.76−0.12 (-4.17%)

Close on Oct 19, 2026

Market cap
$376.75M
P/E (TTM)
1.5
Dividend yield
–

About Community Health Systems

Services-General Medical & Surgical Hospitals, NEC, SIC 8062

Community Health Systems, Inc. operates healthcare delivery systems that provide inpatient and outpatient medical services to patients in local communities. Its service offerings include general acute care, emergency treatment, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostics, psychiatric care, and rehabilitation. In addition to hospital facilities, the company delivers care through outpatient access points such as physician practices, urgent care centers, freestanding emergency departments, imaging facilities, cancer centers, and ambulatory surgery centers. The company serves individual patients, and its revenues derive from payments made by government agencies, private insurance providers, and patients directly.

The company conducts operations across 36 markets in 14 states. Its subsidiaries own or lease 69 affiliated hospitals with more than 10,000 beds, and manage over 1,000 care sites. The organization employs approximately 1,700 physicians and 1,400 licensed healthcare practitioners. The provided text does not identify the company's headquarters.

Summary of the business section of Community Health Systems's latest annual report, written by StockData.

Company profile

Company

Legal name
COMMUNITY HEALTH SYSTEMS INC
Founded
1985
Headquarters
Franklin, TN
Address
4000 Meridian Boulevard 37067
Phone
(615) 465-7000
Website
chs.net
Employees
57,000, Dec 31, 2025
Industry
Services-General Medical & Surgical Hospitals, NEC
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Deloitte & Touche LLP, Nashville, Tennessee

Stock & identifiers

Ticker
CYH
Exchange
NYSE
IPO date
Jun 9, 2000
Shares outstanding
141M, Jul 16, 2026
Public float
$415.20M, Jun 30, 2025
Filer category
Accelerated filer
SEC CIK
1108109
CUSIP
203668108
ISIN
US2036681086
LEI
549300BQWM4WENQ3YW73
EIN
13-3893191

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Tim HingtgenCEO, Director1,267,588
David V. RiceEVP-Clinical Operations & CMO30,000
Jason K. JohnsonEVP & CFO202,049
Kevin J. HammonsCEO992,441
Kevin A. StocktonEVP, Operations & Development213,863
Justin D. PittPres,Chief Legal&Admin Officer300,334
Phillip A. PoseySVP & CAO52,924
Miguel S. BenetPresident and CMO47,635
Austen D. MasonRegional President142,500
Mark B. MedleyRegional President128,637
Chad A. CampbellRegional President150,787
William Norris JenningsDirector38,468
K. Ranga KrishnanDirector170,023
Ronald L. Burgess JrDirector0
John A. ClericoDirector368,763
John A. FryDirector268,966
Michael DinkinsDirector204,976
Fawn D. LopezDirector0
James S. Ely IIIDirector377,027
Wayne T. SmithDirector7,306,142
Hubert James WilliamsDirector171,024
Elizabeth T. HirschDirector142,126
Joseph Arthur HastingsDirector17,130
Susan W. BrooksDirector67,856

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Kevin JHammons
$4.77M$3.91M$2.27M$108$149
FY2025
Tim Hingtgen
$7.85M-$4.99M$2.27M$108$149
FY2024–$7.13M$2.42M$103$132
FY2024
Tim Hingtgen
$7.63M$7.13M$2.42M$103$132
FY2023–$5.92M$2.29M$108$131
FY2023
Tim Hingtgen
$8.35M$5.92M$2.29M$108$131

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“At December 31, 2025, we had approximately 57,000 employees, including approximately 13,000 part-time employees.”

Corporate history

Events identified from SEC filings

DateEventDetails
Jun 1, 2026Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 1, 2026Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Feb 2, 2026Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 2, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jul 1, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 1, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Mar 3, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 1, 2024Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 1, 2023Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 3, 2023Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 3, 2023Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 11, 2019DelistingNotice of delisting from exchange (Form 25)
Apr 4, 2017DelistingNotice of delisting from exchange (Form 25)
Oct 3, 2016ListingRegistration of securities on an exchange (Form 8-A)
Sep 17, 2014MergerRegistration of securities for a merger or exchange offer (S-4)
Jan 28, 2014Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 27, 2014ListingRegistration of securities on an exchange (Form 8-A)
Sep 25, 2013MergerRegistration of securities for a merger or exchange offer (S-4)
Mar 22, 2012MergerRegistration of securities for a merger or exchange offer (S-4)
Jul 28, 2010Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Sep 25, 2007MergerRegistration of securities for a merger or exchange offer (S-4)
Jul 30, 2007Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Feb 24, 2005MergerRegistration of securities for a merger or exchange offer (S-4)
Jun 9, 2000IPOInitial public offering priced (424B4 prospectus)
Jun 5, 2000ListingRegistration of securities on an exchange (Form 8-A)